H M Fillit - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

H M Fillit

Showing results (21-30 of 30) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 30 results.

The American Journal of Managed Care|August 25, 2001

Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspectiveD P Rice, H M Fillit, W Max, et al.

The New England Journal of Medicine|April 20, 1978

Cellular reactivity to altered glomerular basement membrane in glomerulonephritisH M Fillit, S E Read, R L Sherman, et al.

Acta Neuropathologica|January 1, 1994

Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disordersL Buée, P R Hof, C Bouras, et al.

Health Affairs (Project Hope)|September 18, 2001

Public attitudes about genetic testing for Alzheimer's diseaseP J Neumann, J K Hammitt, C Mueller, et al.

Neurochemistry International|June 1, 1997

Heparin promotes beta-secretase cleavage of the Alzheimer's amyloid precursor proteinB Leveugle, W Ding, J T Durkin, et al.

Connective Tissue Research|January 1, 1988

Monoclonal antibodies to heparan sulfate proteoglycan: development and application to the study of normal tissue and pathologic human kidney biopsiesE Kemeny, H M Fillit, S Damle, et al.

Brain Research|November 12, 1993

Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptideL Buée, W Ding, J P Anderson, et al.

The American Journal of Managed Care|October 28, 1999

Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviewsH M Fillit, R Futterman, B I Orland, et al.

Archives of Biochemistry and Biophysics|January 21, 2000

Specificities of heparin-binding sites from the amino-terminus and type 1 repeats of thrombospondin-1H Yu, D Tyrrell, J Cashel, et al.

Journal of Internal Medicine|January 18, 2021

Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesisJ L Liss, S Seleri Assunção, J Cummings, et al.

Pageof 3

Search research articles

Showing results (21-30 of 30) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 30 results.

The American Journal of Managed Care|August 25, 2001

Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspectiveD P Rice, H M Fillit, W Max, et al.

The New England Journal of Medicine|April 20, 1978

Cellular reactivity to altered glomerular basement membrane in glomerulonephritisH M Fillit, S E Read, R L Sherman, et al.

Acta Neuropathologica|January 1, 1994

Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disordersL Buée, P R Hof, C Bouras, et al.

Health Affairs (Project Hope)|September 18, 2001

Public attitudes about genetic testing for Alzheimer's diseaseP J Neumann, J K Hammitt, C Mueller, et al.

Neurochemistry International|June 1, 1997

Heparin promotes beta-secretase cleavage of the Alzheimer's amyloid precursor proteinB Leveugle, W Ding, J T Durkin, et al.

Connective Tissue Research|January 1, 1988

Monoclonal antibodies to heparan sulfate proteoglycan: development and application to the study of normal tissue and pathologic human kidney biopsiesE Kemeny, H M Fillit, S Damle, et al.

Brain Research|November 12, 1993

Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptideL Buée, W Ding, J P Anderson, et al.

The American Journal of Managed Care|October 28, 1999

Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviewsH M Fillit, R Futterman, B I Orland, et al.

Archives of Biochemistry and Biophysics|January 21, 2000

Specificities of heparin-binding sites from the amino-terminus and type 1 repeats of thrombospondin-1H Yu, D Tyrrell, J Cashel, et al.

Journal of Internal Medicine|January 18, 2021

Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesisJ L Liss, S Seleri Assunção, J Cummings, et al.

Pageof 3